PMC9923168_01
Pre-operative visual field test.
fsurg-09-1021680-g001.jpg
PMC9923168_01_fsurg-09-1021680-g001.jpg
F1
In the outpatient department, his visual field test (Figure 1) showed a temporal defect in both eyes.
Pre-operative MRI and CT.
fsurg-09-1021680-g002.jpg
PMC9923168_01_fsurg-09-1021680-g002.jpg
F2
Brain computed tomography (Figure 2) showed increased soft tissue density over the sellar and suprasellar regions. Brain magnetic resonance imaging (Figure 2) was further arranged, which showed a mass with enhancement measuring about 2.3 cm x 2.3 cm x 2.0 cm in size located at the sella with suprasellar extension.
Intraoperative picture. P, normal pituitary gland after tumor removal. T, the gross appearance of the tumor.
fsurg-09-1021680-g003.jpg
PMC9923168_01_fsurg-09-1021680-g003.jpg
F3
Grossly, the tumor was yellow and soft in consistency (Figure 3).
Pathologic report. Histology of the tumor. HE stain, original magnification 400x. Immunohistochemistry stain, TTF-1 (+), EMA (+), S100 (+), original magnification 100x.
fsurg-09-1021680-g004.jpg
PMC9923168_01_fsurg-09-1021680-g004.jpg
F4
Histological examination (Figure 4) showed tumor growth exhibiting spindle to epithelioid cells, featuring eosinophilic and granular cytoplasm.
Post-operative MRI after 18 months.
fsurg-09-1021680-g005.jpg
PMC9923168_01_fsurg-09-1021680-g005.jpg
F5
He was discharged in good condition and has been receiving regular follow-up at our neurosurgery department (Figure 5).